Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

State-of-the-Art Approaches to Rheumatic Disease Diagnosis, Management & Treatment

Lara C. Pullen, PhD  |  Issue: March 2019  |  March 19, 2019

Neurology for the Rheumatologist

Julius Birnbaum, MD, MHS, associate director of the Johns Hopkins Jerome L. Greene Sjögren’s Syndrome Center, Baltimore, gave an overview of neurology for the rheumatologist. He began by describing how neurological examination can be a powerful tool in distinguishing between myelopathies, radiculopathies and neuropathies. He emphasized that distinguishing between a radiculopathy and a neuropathy does not require the memorization of a web of neuroanatomy. He encouraged rheumatologists to forget about most of the cross wiring between the spinal cord and peripheral nerves. Instead, he told the audience they should remember that radiculopathy has more diffuse sensory and motor features, while neuropathy has more focal sensory and motor features.

Dr. Birnbaum talked through an example of a patient who presented with wrist drop, explaining that all the healthcare provider has to do is check the number of affected muscle groups. If the patient has neuropathy, it’s likely only one or a few muscle groups are affected. In contrast, if the patient has weakness in three or more muscle groups, radiculopathy is more likely. Dr. Birnbaum explained the approach to diagnosing foot drop is similar. If the patient has an insidious onset of less severe, but diffuse sensory and motor features, then it’s likely they have L5 radiculopathy. In contrast, the patient who presents with acute severe localized symptoms likely has peroneal neuropathy.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Small fiber neuropathies can present as neuropathic pain in patients with systemic rheumatic diseases. They target thinly myelinated A-delta or unmyelinated C-fiber nerves, and the resulting pain is burning, paroxysmal and allodynic. Patients may even complain of pain when bed sheets graze their toes at night. They often have vivid and remarkable descriptions of neuropathic pain. “It is really amazing, the lyricism,” said Dr. Birnbaum.

For example, he discussed a patient who said, “I feel like my legs are being electrocuted at night.” Physical examination of patients with small fiber neuropathies often reveals small fiber deficits (i.e., decreased pinprick and cold sensation) even though electrodiagnostic studies are normal. Unfortunately, because small fiber neuropathy can be associated with a seronegative profile, it may be difficult for these patients to receive an accurate diagnosis. A delayed diagnosis can contribute to a more widespread and treatment-refractory, centrally sensitized pain state that results from central amplification.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The differential diagnosis of potential small fiber neuropathies includes vasculitis, infection and autoimmune/inflammatory disorders. Metabolic disorders are also important in the differential because impaired glucose tolerance can cause a reversible small fiber neuropathy. It is also important to exclude neoplastic disorders or structural mimics, such as syringomyelia and myeloradiculopathies. A punch skin biopsy will not only be diagnostic for small fiber neuropathy, but may also help identify which part of the peripheral nervous system is being targeted. Patients with vasculitic neuropathies can be treated with immunosuppressive therapy. Painful neuropathies can initially be treated with symptomatic therapies.

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersPain SyndromesSystemic Lupus Erythematosus Tagged with:2018 ACR/ARHP Annual MeetingFibromyalgiaOsteoporosisperioperative period

Related Articles

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences